Literature DB >> 12527637

Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis.

Gregg M Eschun1, Steven N Mink, Sat Sharma.   

Abstract

Microscopic polyangiitis (MPA) is one of the vasculitides that is included in the pulmonary renal syndromes. Pathologically, MPA has been defined as necrotizing vasculitis with few or no immune deposits, primarily affecting small vessels including arterioles, venules, or capillaries. Pulmonary interstitial fibrosis (PIF) as an accompanying manifestation in MPA has not been widely appreciated. In the present study, we report six cases of MPA at our institution with radiographic evidence of PIF that was apparent before any treatment was administered. All had biopsy evidence of renal disease that was consistent with MPA as well as positive serum perinuclear antineutrophilic cytoplasmic antibody titers. Hemoptysis was observed in approximately one half of the patients. As determined by CT of the chest, PIF was detected in all of the patients and was often present years before a diagnosis of MPA was made. We conclude that PIF may occur as a pulmonary manifestation of MPA. Further appreciation of this finding may lead to more data with respect to the incidence of PIF in MPA, and to a better understanding of the mechanisms that are involved in the development of this finding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527637     DOI: 10.1378/chest.123.1.297

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

2.  Microscopic polyangiitis associated with pulmonary fibrosis.

Authors:  Marcelo Fernandez Casares; Alejandra Gonzalez; Mariano Fielli; Flavia Caputo; Yanina Bottinelli; Marcelo Zamboni
Journal:  Clin Rheumatol       Date:  2014-05-27       Impact factor: 2.980

3.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-13       Impact factor: 2.631

Review 4.  Microscopic polyangiitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Rheum Dis Clin North Am       Date:  2010-06-11       Impact factor: 2.670

5.  Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis.

Authors:  O Shields; A Shah; B Mann
Journal:  BMJ Case Rep       Date:  2011-04-15

6.  Anti-neutrophil cytoplasmic antibody-negative microscopic polyangiitis: A case report and literature review.

Authors:  Ran Wang; Xiao-Chun Yang; Si-Jing Zhou; Geng-Yun Sun
Journal:  Exp Ther Med       Date:  2015-05-26       Impact factor: 2.447

Review 7.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-20       Impact factor: 2.631

8.  Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?

Authors:  Amir Bhanji; Mahzuz Karim
Journal:  NDT Plus       Date:  2010-04-14

9.  Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea.

Authors:  Joong Kyong Ahn; Ji-Won Hwang; Jaejoon Lee; Chan Hong Jeon; Hoon-Suk Cha; Eun-Mi Koh
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 3.580

10.  Pulmonary Limited MPO-ANCA Microscopic Polyangiitis and Idiopathic Lung Fibrosis in a Patient with a Diagnosis of IgA Nephropathy.

Authors:  Alwin Tilanus; Patricia Van der Niepen; Caroline Geers; Karl Martin Wissing
Journal:  Case Rep Nephrol       Date:  2015-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.